Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-25-013042

Options or other derivatives

  • Chief Executive Officer acquired 1,669,860 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Collard Craig A Chief Executive Officer 2025-01-31 Grant or award · Employee Stock Option (Right to Buy) +1,113,240 1,113,240 D: show line 1 in the form
Collard Craig A Chief Executive Officer 2025-01-31 Grant or award · Restricted Stock Units +556,620 556,620 D: show line 2 in the form
Loading xslF345X05/ownership.xml…